Cargando…

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

BACKGROUND: This study aims to critically review available cost-effectiveness models for rotavirus vaccination, compare their designs using a standardized approach and compare similarities and differences in cost-effectiveness outcomes using a uniform set of input parameters. METHODS: We identified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Postma, Maarten J, Jit, Mark, Rozenbaum, Mark H, Standaert, Baudouin, Tu, Hong-Anh, Hutubessy, Raymond CW
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158747/ https://www.ncbi.nlm.nih.gov/pubmed/21740545 http://dx.doi.org/10.1186/1741-7015-9-84

Ejemplares similares

An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”
por: Tu, Hong Anh T, et al.
Publicado: (2013)

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
por: Rozenbaum, Mark H, et al.
Publicado: (2011)

Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool)
por: Morgan, Winthrop, et al.
Publicado: (2020)

Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data
por: Standaert, Baudouin, et al.
Publicado: (2013)

Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
por: Knoll, Stefanie, et al.
Publicado: (2013)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country
por: Standaert, Baudouin
Publicado: (2023)

Comparing Cost-Effectiveness Results for a Vaccine Across Different Countries Worldwide: What Can We Learn?
por: Standaert, Baudouin, et al.
Publicado: (2014)

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe
por: Standaert, Baudouin, et al.
Publicado: (2022)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
por: Carvalho, Natalie, et al.
Publicado: (2017)

Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS)
por: Standaert, Baudouin, et al.
Publicado: (2015)

Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States
por: Weycker, Derek, et al.
Publicado: (2014)

Budget constraint and vaccine dosing: a mathematical modelling exercise
por: Standaert, Baudouin A, et al.
Publicado: (2014)

Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)
por: Standaert, Baudouin, et al.
Publicado: (2020)

Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia
por: Suwantika, Auliya A, et al.
Publicado: (2013)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Improving the Hospital Quality of Care during Winter Periods by Optimizing Budget Allocation Between Rotavirus Vaccination and Bed Expansion
por: Dort, Thibaut, et al.
Publicado: (2017)

803 Direct Costs and Duration of Hospitalization of Patients Hospitalized with Community Acquired Pneumonia: a Nationwide Retrospective Claims Database Analysis
por: Rozenbaum, Mark, et al.
Publicado: (2014)

Exploring the potential impact of rotavirus vaccination on work absenteeism among female administrative personnel of the City of Antwerp through a retrospective database analysis
por: Standaert, Baudouin, et al.
Publicado: (2015)

A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda
por: Ngabo, Fidèle, et al.
Publicado: (2015)

The Sustained Rotavirus Vaccination Impact on Nosocomial Infection, Duration of Hospital Stay, and Age: The RotaBIS Study (2005–2012)
por: Standaert, Baudouin, et al.
Publicado: (2016)

Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
por: van der Putten, Ingeborg M, et al.
Publicado: (2015)

Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium
por: Standaert, B, et al.
Publicado: (2015)

Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?
por: Urbanus, Anouk T., et al.
Publicado: (2013)

Informing decision makers seeking to improve vaccination programs: case-study Serbia
por: Sauboin, Christophe, et al.
Publicado: (2021)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs
por: Standaert, Baudouin, et al.
Publicado: (2020)

Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?
por: Postma, Maarten J., et al.
Publicado: (2022)

CostPlus and implications for generic imatinib
por: Jenei, Kristina, et al.
Publicado: (2022)

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review
por: Vondeling, Gerard T., et al.
Publicado: (2018)

A review of the costs of delivering maternal immunisation during pregnancy
por: Procter, Simon R, et al.
Publicado: (2020)

Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam
por: Riewpaiboon, Arthorn, et al.
Publicado: (2016)

Reducing Malaria Mortality at the Lowest Budget: An Optimization Tool for Selecting Malaria Preventative Interventions Applied to Ghana
por: Sauboin, Christophe, et al.
Publicado: (2019)

Impact of Generic Alendronate Cost on the Cost-Effectiveness of Osteoporosis Screening and Treatment
por: Nayak, Smita, et al.
Publicado: (2012)

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
por: Deogaonkar, Rohan, et al.
Publicado: (2012)

Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization
por: Jit, Mark, et al.
Publicado: (2015)

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector
por: Hutubessy, Raymond, et al.
Publicado: (2003)

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
por: Xia, Changfa, et al.
Publicado: (2021)

WHO-led consensus statement on vaccine delivery costing: process, methods, and findings
por: Levin, Ann, et al.
Publicado: (2022)

1439. The Cost-Effectiveness of Vaccinating Adults at Increased Risk of Pneumococcal Disease Against Pneumococcal Disease in The Netherlands
por: Rozenbaum, Mark
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pvqrm4pqv1rasum3mblcrike0h